Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 2 Interventional

R-Flurbiprofen in Treating Patients With Localized Prostate Cancer at Risk of Recurrence

ClinicalTrials.gov ID: NCT00045123

Public ClinicalTrials.gov record NCT00045123. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 9:32 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase IIB, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Efficacy of MPC-7869 in Delaying the Systemic Progression of Prostate Cancer in Patients With Intermediate to High Risk of Recurrence With Rising PSA Levels After Prostatectomy, Prostatectomy and Radiotherapy or Radiotherapy Alone for Localized Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. R-flurbiprofen may be effective in delaying the recurrence of localized prostate cancer. PURPOSE: Randomized phase II trial to study the effectiveness of R-flurbiprofen in treating patients who have localized prostate cancer at risk of recurrence following radiation therapy and/or prostatectomy.

Study identification

NCT ID
NCT00045123
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Myrexis Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 2002 (Type not available)
Primary completion
Not listed
Completion
Not listed
Last update posted
Dec 18, 2013

Started 2002

United States locations

U.S. sites
58
U.S. states
30
U.S. cities
52
Facility City State ZIP Site status
Urology Centers of Alabama Homewood Alabama 35209 —
Alaska Clinical Research Center, LLC Anchorage Alaska 99508 —
Urology Associates Of Central California Fresno California 93720 —
Orange County Urology Associates Laguna Hills California 92653 —
South Orange County Hematology-Oncology Associates Laguna Hills California 92653 —
Loma Linda University Cancer Institute at Loma Linda University Medical Center Loma Linda California 92354 —
Atlantic Urology Medical Group Long Beach California 90806 —
Jonsson Comprehensive Cancer Center, UCLA Los Angeles California 90095-7187 —
San Diego Urological Medical Group San Diego California 92101 —
Coastal Medical Research Group, Incorporated San Luis Obispo California 93401 —
Urology Associates - Research Denver Colorado 80210 —
Walter Reed Army Medical Center Washington D.C. District of Columbia 20307-5001 —
South Florida Medical Research Aventura Florida 33180 —
Lynn Regional Cancer Center West Boca Raton Florida 33428 —
21st Century Oncology - Fort Myers Fort Myers Florida 33901-8082 —
UroSearch - Ocala Ocala Florida 34471 —
Rice, Lake and Harper Urology, LLC Columbus Georgia 31904 —
North Idaho Urology Coeur d'Alene Idaho 83814 —
Cancer Care Specialists of Central Illinois, S.C. - Decatur Decatur Illinois 62526 —
Decatur Memorial Hospital Cancer Care Institute Decatur Illinois 62526 —
Evanston Northwestern Health Care - Evanston Hospital Evanston Illinois 60201-1781 —
Northeast Indiana Research, LLC Fort Wayne Indiana 46825-1675 —
Cancer Center at Lexington Clinic Lexington Kentucky 40504 —
Regional Urology, L.L.C. Shreveport Louisiana 71101 —
St. Agnes Cancer Center Baltimore Maryland 21229 —
Drs. Werner, Murdock and Francis, P.A., Urology Associates Greenbelt Maryland 20770 —
Lakeside Urology, P.C. Saint Joseph Michigan 49085 —
Mallinckrodt Institute of Radiology St Louis Missouri 63110 —
Not listed Las Vegas Nevada 89109 —
Lawrenceville Urology Lawrenceville New Jersey 08648 —
Center for Urologic Care Voorhees Township New Jersey 08043 —
Veterans Affairs Medical Center - Albany Albany New York 12208 —
AccuMed Research Associates Garden City New York 11530 —
Staten Island Urologic Oncology Staten Island New York 10305 —
Urology Center Greensboro North Carolina 27401 —
Charles M. Barrett Cancer Center at University Hospital Cincinnati Ohio 45267-0589 —
Ireland Cancer Center Cleveland Ohio 44106-5046 —
Urological Associates, Incorporated Columbus Ohio 43222 —
Oregon Urology Specialists Eugene Oregon 97401 —
Center for Urologic Care Bryn Mawr Pennsylvania 19010 —
Urological Associates of Lancaster, Ltd. Lancaster Pennsylvania 17604 —
Center of Urologic Care of Berks County West Reading Pennsylvania 19611 —
Rhode Island Hospital Providence Rhode Island 02903 —
University Urological Research Institute Providence Rhode Island 02904 —
Grand Strand Urology LLP Myrtle Beach South Carolina 29572 —
University of Tennessee - Graduate School of Medicine Knoxville Tennessee 37920 —
Urology Associates Nashville Tennessee 37209 —
Urology Associates of North Texas Arlington Texas 76012 —
Urology Clinics of North Texas Dallas Texas 75231 —
Baylor University Medical Center Dallas Texas 75246 —
Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas Texas 75390-9110 —
Urology Consultants, P.A. San Antonio Texas 78229 —
Center for Cancer Prevention and Care at Scott and White Clinic Temple Texas 76508 —
Salt Lake Research Salt Lake City Utah 84124 —
Vermont Cancer Center at University of Vermont Burlington Vermont 05405-0075 —
Northwest Hospital and Medical Center Seattle Washington 98133 —
Highline Hospital Campus Seattle Washington 98166 —
University of Wisconsin Comprehensive Cancer Center Madison Wisconsin 53715 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00045123, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2013 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00045123 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →